#ThinkSabio Latest News
GlycoMimetics, Inc. announced that data from several clinical trials on uproleselan for acute myeloid leukemia (AML) will be presented at the 66th ASH Annual Meeting in San Diego, December 7-10.
GlycoMimetics, Inc. announced that data from several clinical trials on uproleselan for acute myeloid leukemia (AML) will be presented at the 66th ASH Annual Meeting in San Diego, December 7-10.